• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of the clinicopathological and imaging features in breast intraductal papillary lesions with or without pathological nipple discharge.伴有或不伴有病理性乳头溢液的乳腺导管内乳头状病变的临床病理及影像学特征分析
Sci Rep. 2025 Jan 20;15(1):2478. doi: 10.1038/s41598-025-87278-z.
2
The "Trunk sign": A novel X-ray sign in galactography of patients with nipple discharge suggesting malignancy.“干酪样征”:一种提示恶性病变的新型 X 线征象,在伴有乳头溢液的乳管造影中出现。
Medicine (Baltimore). 2023 Aug 11;102(32):e34589. doi: 10.1097/MD.0000000000034589.
3
Retrospective statistical analysis on the diagnostic value of ductography based on lesion pathology in patients presenting with nipple discharge.基于病变病理的乳头溢液患者导管造影的诊断价值回顾性统计分析。
Breast J. 2019 Jul;25(4):585-589. doi: 10.1111/tbj.13298. Epub 2019 May 13.
4
The diagnostic value of cytology in the mammary intraductal lesions of patients with pathological nipple discharge.细胞学检查在病理性乳头溢液患者乳腺导管内病变中的诊断价值。
Sci Rep. 2025 Jan 25;15(1):3243. doi: 10.1038/s41598-025-86533-7.
5
Intraductal laser ablation during ductoscopy in patients with pathological nipple discharge.病理性乳头溢液患者行乳管镜检查时的导管内激光消融术。
Breast Cancer Res Treat. 2025 Apr;210(2):329-335. doi: 10.1007/s10549-024-07568-4. Epub 2025 Feb 4.
6
The role of breast ductoscopy in evaluation of nipple discharge: a chinese experience of 419 patients.乳腺导管内镜检查在乳头溢液评估中的作用:419例患者的中国经验
Breast J. 2014 Jul-Aug;20(4):388-93. doi: 10.1111/tbj.12275.
7
Clinicopathological and Imaging Features of Breast Papillary Lesions and Their Association with Pathologic Nipple Discharge.乳腺乳头状病变的临床病理及影像学特征及其与病理性乳头溢液的关系
Diagnostics (Basel). 2023 Feb 24;13(5):878. doi: 10.3390/diagnostics13050878.
8
The Diagnostic Value of microRNA Expression Analysis in Detecting Intraductal Papillomas in Patients with Pathological Nipple Discharge.微 RNA 表达分析在病理性乳头溢液患者中检测导管内乳头状瘤的诊断价值。
Int J Mol Sci. 2024 Feb 2;25(3):1812. doi: 10.3390/ijms25031812.
9
A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real-world experience.回顾性观察性研究乳腺导管内乳头状瘤及其共存病变:真实世界的经验。
Cancer Med. 2020 Oct;9(20):7751-7762. doi: 10.1002/cam4.3308. Epub 2020 Aug 21.
10
Diagnostic value of sialyl-Tn immunocytochemistry in breast cancer presenting with pathological nipple discharge.在伴有病理性乳头溢液的乳腺癌中,唾液酸化 Tn 免疫细胞化学的诊断价值。
Cancer Med. 2021 Mar;10(5):1783-1790. doi: 10.1002/cam4.3793. Epub 2021 Feb 19.

本文引用的文献

1
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).第三版乳腺交界性病变国际专家共识(B3 病变)
Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17.
2
Clinicopathological and Imaging Features of Breast Papillary Lesions and Their Association with Pathologic Nipple Discharge.乳腺乳头状病变的临床病理及影像学特征及其与病理性乳头溢液的关系
Diagnostics (Basel). 2023 Feb 24;13(5):878. doi: 10.3390/diagnostics13050878.
3
Papillary Carcinoma of Breast: Clinicopathological Characteristics, Management, and Survival.乳腺乳头状癌:临床病理特征、治疗与生存情况
Int J Breast Cancer. 2022 Oct 13;2022:5427837. doi: 10.1155/2022/5427837. eCollection 2022.
4
ASO Author Reflections: De-escalation of Surgical Excision for Intraductal Papilloma of the Breast.ASO作者反思:乳腺导管内乳头状瘤手术切除的降级处理
Ann Surg Oncol. 2022 Dec;29(Suppl 3):593-594. doi: 10.1245/s10434-021-10637-3. Epub 2022 Feb 24.
5
Papillary lesions of the breast.乳腺的乳头状病变。
Virchows Arch. 2022 Jan;480(1):65-84. doi: 10.1007/s00428-021-03182-7. Epub 2021 Nov 3.
6
Solid Papillary Carcinoma and Encapsulated Papillary Carcinoma of the Breast: Clinical-Pathologic Features and Basement Membrane Studies of 50 Cases.乳腺实性乳头状癌和包膜型乳头状癌:50 例临床病理特征和基底膜研究。
Pathobiology. 2021;88(5):359-373. doi: 10.1159/000517189. Epub 2021 Jul 15.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Histological type and typing of breast carcinomas and the WHO classification changes over time.乳腺癌的组织学类型及分型以及世界卫生组织的分类随时间而变化。
Pathologica. 2020 Mar;112(1):25-41. doi: 10.32074/1591-951X-1-20.
9
Risk of malignancy in papillary neoplasms of the breast.乳腺乳头状肿瘤的恶性风险。
Breast Cancer Res Treat. 2019 Nov;178(1):87-94. doi: 10.1007/s10549-019-05367-w. Epub 2019 Jul 22.
10
Treatment and Outcome of 341 Papillary Breast Lesions.341 例乳腺乳头状病变的治疗和转归。
World J Surg. 2019 Oct;43(10):2477-2482. doi: 10.1007/s00268-019-05047-2.

伴有或不伴有病理性乳头溢液的乳腺导管内乳头状病变的临床病理及影像学特征分析

Analysis of the clinicopathological and imaging features in breast intraductal papillary lesions with or without pathological nipple discharge.

作者信息

Pu Qian, Li Peng, Su Minghui, Gao Dezong

机构信息

Department of Breast Surgery, Cheeloo College of Medicine, Qilu Hospital (Qingdao), Shandong University, 758 Hefei Road, Qingdao, 266000, Shandong, China.

Oncology Laboratory, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, 266000, Shandong, China.

出版信息

Sci Rep. 2025 Jan 20;15(1):2478. doi: 10.1038/s41598-025-87278-z.

DOI:10.1038/s41598-025-87278-z
PMID:39833359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11747485/
Abstract

With the popularity of breast screening, more and more intraductal papillary lesions (IDPL)were detected by ultrasound or mammography, which is a spectrum of diseases ranging from benign to malignant lesions. Patients with pathological nipple discharge (PND) may indicate IDPL, but it is difficult to clarify their biological characteristics before the operation. As to patients with IDPL without PND, it is even an enormous challenge to differentiate their benign or malignant characteristics. Therefore, to avoid inadequate treatment, it is necessary to analyze the clinicopathological and imaging characteristics of patients with papillary lesions before surgery for the preliminary diagnosis of benign or malignant papillary lesions. 267 cases of IDPL with or without PND, namely PND group and non-PND group, were studied using continuous clinical data from October 2020 to September 2023. We analyzed the clinicopathological and imaging characteristics in the two groups of patients with malignancy compared with benign patients. Meanwhile, these characteristics were analyzed in malignant papillary patients with PND or not. 267 patients were pathologically diagnosed with IDPL during three years, accounting for 15.4% of surgical cases of the same period. There were 55 patients with malignant lesions (20.6%), including 28 cases in the PND group (16.5%) and 27 cases in the non-PND group (27.8%), and the incidence of malignant lesions was higher in the non-PND group than that of the PND group. There was a close correlation between age and malignant lesions in the two groups; the number of patients older than 50 years in malignant patients (74.5%) exceeded that of benign patients (42.5%). There were nearly one-third of malignancies in patients with nipple bloody discharge, and the rate increased to 50% when the patient was older than 50 years, but the malignant rate was meager in patients without bloody discharge. There were some factors relating to malignancy in non-PND patients, including age, lesion size, the distance from the nipple to the lesson (DFNL), and abnormal mammogram; there was a significant difference in this positive manifestation between benign and malignant patients. In malignant intraductal papillary lesions, 40.8% of the cases were invasive carcinoma in the non-PND group, higher than in the PND group (10.7%). Meanwhile, immunohistochemistry was more likely to be hormone receptor-positive (92.6%) and Her-2 negative in the non-PND group, compared with the PND group. Breast IDPL is a common disease, among which malignant lesions are higher than reports in previous literature. There are some clinical and imaging manifestations indicating malignancy; patients more than 50 years old with bloody nipple discharge are at high risk of malignancy. When old non-PND patients have more significant lesions, remote DFNL, and abnormal mammograms, there is a high probability of malignancy in them. Although there are different biological characteristics in malignant IDPL with or without PND, they are all low-grade malignancies compared with traditional breast cancer.

摘要

随着乳腺筛查的普及,越来越多的导管内乳头状病变(IDPL)通过超声或乳腺钼靶检查被发现,这是一类涵盖从良性到恶性病变的疾病谱。有乳头溢液(PND)的患者可能提示IDPL,但术前难以明确其生物学特性。对于无PND的IDPL患者,鉴别其良性或恶性特征更是一项巨大挑战。因此,为避免治疗不足,术前分析乳头状病变患者的临床病理及影像特征以初步诊断良性或恶性乳头状病变很有必要。本研究使用2020年10月至2023年9月的连续临床数据,对267例有或无PND的IDPL患者,即PND组和非PND组进行了研究。我们分析了两组恶性患者与良性患者相比的临床病理及影像特征。同时,对有或无PND的恶性乳头状患者的这些特征也进行了分析。三年间有267例患者经病理诊断为IDPL,占同期手术病例的15.4%。其中有55例恶性病变患者(20.6%),PND组有28例(16.5%),非PND组有27例(27.8%),非PND组恶性病变的发生率高于PND组。两组中年龄与恶性病变密切相关;恶性患者中年龄大于50岁的患者数量(74.5%)超过良性患者(42.5%)。乳头血性溢液患者中近三分之一为恶性,当患者年龄大于50岁时该比例增至50%,但无血性溢液患者的恶性率较低。非PND患者存在一些与恶性相关的因素,包括年龄、病变大小、乳头至病变的距离(DFNL)及乳腺钼靶异常;良性和恶性患者在这种阳性表现上存在显著差异。在恶性导管内乳头状病变中,非PND组40.8%的病例为浸润性癌,高于PND组(10.7%)。同时,与PND组相比,非PND组免疫组化更易呈激素受体阳性(92.6%)且Her-2阴性。乳腺IDPL是一种常见疾病,其中恶性病变高于既往文献报道。存在一些提示恶性的临床和影像表现;年龄大于50岁且有乳头血性溢液的患者恶性风险高。老年非PND患者病变较大、DFNL较远且乳腺钼靶异常时,其恶性可能性高。尽管有或无PND的恶性IDPL具有不同的生物学特征,但与传统乳腺癌相比,它们均为低级别恶性肿瘤。